Cultural Competence in the Community
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
Progress Against Cancer
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain.
Get your hearing checked periodically if you will be undergoing chemotherapy with neurotoxic effects.
Early-onset cancer is increasing globally, testing population-wide preventive DNA testing, and more from the week in cancer news.
The immune checkpoint inhibitor durvalumab was approved in combination with chemotherapy for certain biliary tract cancers that have spread. The U.S. Food and Drug Administration (FDA) has approved durvalumab (Imfinzi) in combination with the...
Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.
Advanced cervical cancer rates are rising despite prevention and screening tools and more from the week in cancer news, selected by the editors of Cancer Today.
An inhibitor of the growth-stimulating FGFR1 protein was approved for patients with a rare type of blood cancer. The U.S. Food and Drug Administration (FDA) has approved pemigatinib (Pemazyre) for adult patients with relapsed...
Link found between fracking wells and leukemia in children, and more from this week in cancer news.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now